Results 81 to 90 of about 355,625 (242)

Invasive pneumococcal disease in relation to vaccine type serotypes

open access: yesHuman Vaccines & Immunotherapeutics, 2019
Since 1983 the world has been introduced to four vaccines combating disease caused by Streptococcus pneumoniae bacteria. However, despite vaccination programs disease caused by S.
Paeton L. Wantuch, F. Avci
semanticscholar   +1 more source

Updates on Toll‐Like Receptor 10 Research

open access: yesEuropean Journal of Immunology, Volume 55, Issue 5, May 2025.
Toll‐like receptor 10 (TLR10 or CD290) shares the same structural organization as the other TLRs but shows a unique expression pattern and distinct functional activities yet to be fully elucidated. This review summarizes key steps and recent updates on TLR10 research including open questions and future perspectives.
Federica Riva, Marta Muzio
wiley   +1 more source

Invasive isolates of Streptococcus pneumoniae in Serbia: Antimicrobial susceptibility and serotypes [PDF]

open access: yesSrpski Arhiv za Celokupno Lekarstvo, 2013
Introduction. Streptococcus pneumoniae is one of the leading causes of bacterial meningitis and sepsis. Invasive pneumococcal disease is a significant medical problem worldwide, particularly in children, due to a huge increase of pneumococcal ...
Gajić Ina   +5 more
doaj   +1 more source

Monitoring the introduction of pneumococcal conjugate vaccines into West Africa: design and implementation of a population-based surveillance system. [PDF]

open access: yes, 2012
Routine use of pneumococcal conjugate vaccines (PCVs) in developing countries is expected to lead to a significant reduction in childhood deaths. However, PCVs have been associated with replacement disease with non-vaccine serotypes.
Adegbola, Richard A   +18 more
core   +2 more sources

Microbiological Analysis of Lower Airway Samples: Does It Influence the Outcome in Patients With Community‐Acquired Pneumonia?

open access: yesAPMIS, Volume 133, Issue 5, May 2025.
ABSTRACT This prospective randomized trial examined the impact of extensive lower respiratory tract sampling and microbial analysis on treatment decisions and patient outcomes in community‐acquired pneumonia (CAP). One hundred and eighteen patients were randomized to rigorous sampling (intervention group, n = 64) or standard care (control group, n = 54)
Peter Ellekvist   +8 more
wiley   +1 more source

The remaining challenges of pneumococcal disease in adults [PDF]

open access: yesEuropean Respiratory Review, 2012
Pneumococcal disease can be divided into invasive disease, i.e. when bacteria are detected in normally sterile body fluids, and noninvasive disease. Pneumococcal disease occurs more frequently in younger children and older adults.
E. Ludwig   +4 more
doaj  

Asthma and the Risk of Invasive Pneumococcal Disease: A Meta-analysis

open access: yesPediatrics, 2019
After introduction of PCV, children with asthma continue to have a higher risk of IPD and pneumonia than children without asthma. CONTEXT: Invasive pneumococcal disease (IPD) and pneumonia are a leading cause of morbidity and mortality throughout the ...
J. Castro-Rodriguez, K. Abarca, E. Forno
semanticscholar   +1 more source

Hopf-bifurcation analysis of pneumococcal pneumonia with time delays [PDF]

open access: yesarXiv, 2019
In this paper, a mathematical model of pneumococcal pneumonia with time delays is proposed. The stability theory of delay differential equations is used to analyze the model. The results show that the disease-free equilibrium is asymptotically stable if the control reproduction ratio R0 is less than unity and unstable otherwise.
arxiv  

Beyond Childhood: Adult and Adolescent Sickle Cell Disease and Outcomes in Northern Ghana

open access: yeseJHaem, Volume 6, Issue 2, April 2025.
ABSTRACT Background Adults and adolescents face different barriers to healthcare utilization compared to children. Objective To describe adult and adolescent sickle cell disease (SCD) and outcomes in northern Ghana. Methods This was a retrospective cohort study of SCD patients aged 13 years and above, admitted between January 1, 2021 and December 31 ...
Kwadwo Faka Gyan   +8 more
wiley   +1 more source

Pneumococcal Polysaccharide Vaccination in Pediatric Inflammatory Bowel Disease

open access: yesGlobal Pediatric Health, 2019
According to current recommendations, in addition to 13-valent pneumococcal conjugate vaccine (PCV13) series, all children with inflammatory bowel disease (IBD) aged ≥2 years, with planned or current immunosuppression, should receive pneumococcal ...
Tsega Temtem MD   +2 more
doaj   +1 more source

Home - About - Disclaimer - Privacy